Proposed pathophysiological crosstalk between MAFLD and CKD.

This schematic illustrates the proposed pathophysiological crosstalk between Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Chronic Kidney Disease (CKD). Panel A depicts organ-specific mechanisms: in the liver, steatosis (lipid-laden h...

Descrición completa

Gardado en:

Detalles Bibliográficos
Autor Principal:	Zienab M. Saad (22676502) (author)
Outros autores:	Hesham K. H. Keryakos (22676505) (author), Hala A. Hassanin (22676508) (author), Mahmoud M. Higazi (22676511) (author), Manar M. Sayed (22676514) (author), Doaa E. Ismail (22676517) (author), Safaa M. Abdelhalim (21398199) (author)
Publicado:	2025
Subjects:	Medicine Cell Biology Biotechnology Marine Biology Cancer Infectious Diseases Virology shear wave elastography patients remains underexplored mitigate progression risks higher liver stiffness 56 ± 17 43 ± 17 5 ± 28 ></ b >). ></ b >), ></ b >) shared metabolic abnormalities 9 ± 39 invasive fibrosis scores 45 ± 1 2 ± 5 mafld patients also dialysis ckd patients 108 ckd patients metabolic risk factors 5 ± 6 9 ± 1 5 ± 3 6 ± 1 xlink "> mafld xlink "> 5 %, b >< metabolic dysfunction 9 ml risk populations fibrosis severity advanced fibrosis 1 years 2 vs ckd severity 1 vs 6 vs study aimed sectional study participants stratified older age nafld score management strategies lower egfr integrated screening insulin resistance findings highlight diagnostic criteria bidirectional relationship apri score
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Proposed pathophysiological crosstalk between MAFLD and CKD.

Títulos similares